COVID vaccine study for teens with juvenile arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at giving a COVID-19 vaccine to teens who have juvenile idiopathic arthritis, to see how they respond. It may help doctors understand vaccine safety and effectiveness for this specific age and condition group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 18 years old (as of January 1, 2022).
- You have a diagnosis of juvenile idiopathic arthritis.
- You were being followed for your juvenile arthritis in 2021.
- You were being followed for your juvenile arthritis in 2022.
- You are not under age 12.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children with arthritis to better understand their condition using clinical exams, lab tests, and ultrasounds. It may help doctors learn more about different types of juvenile arthritis.
This study tests if a pneumonia vaccine (PCV20) is safe and works well in children and young adults with certain autoimmune rheumatic diseases like juvenile arthritis, lupus, or dermatomyositis. It aims to help protect them from serious infections.
This study follows children and young adults newly diagnosed with certain types of arthritis or related conditions to learn more about their health over time. It may help doctors better understand how these diseases progress and how treatments work.
This study follows children and teens who have an inflammatory rheumatism condition that started in childhood. It aims to better understand these illnesses and how they affect young people over time.
This Phase 3 trial studies how well upadacitinib (a pill) and tocilizumab (a shot/IV medicine) improve symptoms and inflammation in children with active systemic juvenile idiopathic arthritis (sJIA). It also looks at side effects and how these medicines move through the body.
This study looks at pain in kids with juvenile arthritis compared to healthy kids. It may help researchers understand pain better and improve future treatments.
Hear when a new SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.